NewGenIvf Group (NIVF) Competitors $1.92 +0.02 (+1.05%) Closing price 03:59 PM EasternExtended Trading$1.89 -0.03 (-1.56%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. CCM, MRAI, BRTX, BGLC, MGRX, SSY, VSEE, DHAC, ACON, and ATIPShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Concord Medical Services (CCM), Marpai (MRAI), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), VSee Health (VSEE), Digital Health Acquisition (DHAC), Aclarion (ACON), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Its Competitors Concord Medical Services Marpai Biorestorative Therapies BioNexus Gene Lab Mangoceuticals SunLink Health Systems VSee Health Digital Health Acquisition Aclarion ATI Physical Therapy Concord Medical Services (NYSE:CCM) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Is CCM or NIVF more profitable? Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A NewGenIvf Group N/A N/A N/A Do institutionals and insiders believe in CCM or NIVF? 66.2% of NewGenIvf Group shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings & valuation, CCM or NIVF? NewGenIvf Group has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$52.60M0.43-$42.23MN/AN/ANewGenIvf Group$5.43M0.30-$520KN/AN/A Does the media favor CCM or NIVF? In the previous week, Concord Medical Services and Concord Medical Services both had 1 articles in the media. NewGenIvf Group's average media sentiment score of 1.87 beat Concord Medical Services' score of -1.00 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Overall Sentiment Concord Medical Services Negative NewGenIvf Group Very Positive Which has more risk & volatility, CCM or NIVF? Concord Medical Services has a beta of -0.94, suggesting that its share price is 194% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.09, suggesting that its share price is 109% less volatile than the S&P 500. SummaryNewGenIvf Group beats Concord Medical Services on 4 of the 7 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65M$7.57B$5.58B$9.81BDividend YieldN/A2.72%4.60%4.10%P/E RatioN/A71.9030.2825.72Price / Sales0.3026.82388.6180.21Price / CashN/A25.8737.7558.93Price / Book-0.0118.428.456.01Net Income-$520K$243.10M$3.25B$265.06M7 Day Performance3.78%4.54%4.05%2.80%1 Month Performance-39.44%0.47%4.32%1.68%1 Year Performance-99.77%18.30%36.25%29.59% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf GroupN/A$1.92+1.1%N/A-99.8%$1.65M$5.43M0.00N/APositive NewsCCMConcord Medical Services0.4711 of 5 stars$5.53+3.5%N/A-30.4%$24.04M$52.60M0.00970Negative NewsShort Interest ↑Gap DownMRAIMarpaiN/A$1.35+14.4%N/A+139.3%$22.50M$34.87M-0.51150News CoverageBRTXBiorestorative Therapies2.5328 of 5 stars$1.47-1.0%$18.00+1,128.7%+6.4%$10.99M$400K-1.007Earnings ReportAnalyst RevisionBGLCBioNexus Gene Lab0.1644 of 5 stars$6.00-9.7%N/A+23.8%$10.76M$9.51M0.0030Short Interest ↑MGRXMangoceuticals0.6801 of 5 stars$1.76+0.6%N/A-97.7%$9.10M$511.08K-0.383Positive NewsEarnings ReportShort Interest ↑SSYSunLink Health Systems1.6128 of 5 stars$0.98-12.6%N/A+20.0%$7.25M$31.09M7.361,376Short Interest ↓VSEEVSee Health2.0417 of 5 stars$1.33-4.3%$5.00+275.9%-54.2%$4.79MN/A0.00N/AShort Interest ↓DHACDigital Health AcquisitionN/A$1.21-6.2%N/A-53.9%$4.36MN/A0.002,021Gap DownACONAclarion1.7808 of 5 stars$7.13+1.8%$11,758.50+164,931.6%-99.7%$4.15M$54.60K0.007Earnings ReportGap UpATIPATI Physical TherapyN/A$0.68flatN/A-88.5%$2.98M$741.86M-0.045,600 Related Companies and Tools Related Companies Concord Medical Services Alternatives Marpai Alternatives Biorestorative Therapies Alternatives BioNexus Gene Lab Alternatives Mangoceuticals Alternatives SunLink Health Systems Alternatives VSee Health Alternatives Digital Health Acquisition Alternatives Aclarion Alternatives ATI Physical Therapy Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access